全球道德藥品市場，依治療類別、最終用戶、地理位置。

Global Ethical Pharmaceuticals Market, By Therapeutic Class, By End User, By Geography .

出版日期: 2024年02月29日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2024 年道德藥品市場價值為 47.6 億美元，預計到 2031 年將達到 94.3 億美元，2024 年至 2031 年年複合成長率(CAGR) 為 10.3%。

報告範圍		報告詳情
基準年：	2023年	2023/2024 年市場規模：	47.6 億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測期間 2023/2024 至 2030/2031 年複合成長率：	10.30%	2030/2031 價值預測：	94.3 億美元

全球道德藥品市佔率 (%)，依地區，2024 年

道德藥品市場專注於開發和製造具有強大功效和安全性的藥物，同時保持高標準的道德、永續性和企業社會責任。這個快速成長的區隔市場是由消費者對負責任的製藥實踐的認知不斷提高以及對通過透明的臨床試驗測試的藥物的偏好所推動的，這些藥物可以最大限度地減少對人類健康的風險。隨著道德標準在患者和醫療保健提供者中變得越來越重要，越來越多的製藥商正在接受道德研究、知情同意、環境管理和公平定價的原則，以在這個市場上獲得競爭優勢。

市場動態：

道德藥品市場主要是由對安全、永續生產和經過道德測試的藥物不斷成長的需求所推動的。圍繞臨床試驗和製造實踐的嚴格監管規範也推動了這一領域的發展。此外，領先的創新公司增加對倫理藥物開發的投資也帶來了利潤豐厚的機會。然而，與道德合規和永續發展措施相關的高成本仍然是市場參與者面臨的主要課題。此外，學名藥競爭日益激烈導致的定價壓力也可能成為一種限制。採用區塊鏈和人工智慧平台來提高透明度是實現跨價值鏈即時資料共享的另一個關鍵趨勢。

研究的主要特點：

該報告對全球倫理藥品市場進行了深入分析，並提供了預測期（2024-2031）的市場規模和年複合成長率（CAGR%），以2023年為基準年。
它闡明了不同區隔市場的潛在收入成長機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
它根據以下參數（例如公司亮點、產品組合、主要亮點、財務表現和策略）對全球倫理藥品市場的主要參與者進行了介紹。
本研究涵蓋的主要公司包括雅培實驗室、艾伯維公司、強生公司、羅氏公司、安進公司、默克公司、葛蘭素史克公司、賽諾菲公司、諾華公司、大塚控股公司、禮來公司、梯瓦製藥工業有限公司、輝瑞公司和武田製藥公司。
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球道德藥品市場報告迎合了該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
利害關係人可以透過用於分析全球道德藥品市場的各種策略矩陣輕鬆做出決策。

介紹
北美洲
美國
加拿大
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
澳洲
韓國
東協
亞太其他地區
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地區
中東
海灣合作理事會
以色列
中東其他地區
非洲
南非
北非
中非

第 7 章：公司簡介 - 全球道德藥品市場

Amgen Inc
- 公司簡介
- 產品/服務組合
- 財務績效
- 最新動態/更新
- 戰略概覽
AbbVie Inc
Johnson & Johnson
Eli Lilly and Company
Merck & Co., Inc
GlaxoSmithKline plc
Sanofi
Novartis AG
Abbott Laboratories
Otsuka Holdings
F. Hoffmann-La Roche Ltd
Teva Pharmaceutical Industries Ltd.
Pfizer Inc
Takeda Pharmaceutical Company

第 8 章：參考文獻與研究方法

參考
研究方法論

簡介目錄

Product Code: CMI6701

The ethical pharmaceuticals market is estimated to be valued at USD 4.76 Bn in 2024 and is expected to reach USD 9.43 Bn by 2031, growing at a compound annual growth rate (CAGR) of 10.3% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 4.76 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	10.30%	2030/2031 Value Projection:	US$ 9.43 Bn

Global Ethical Pharmaceuticals Market Share (%), By Region, 2024

Global Ethical Pharmaceuticals Market - IMG1

The ethical pharmaceuticals market focuses on developing and manufacturing drugs with strong efficacy and safety profiles while maintaining high standards of ethics, sustainability, and corporate social responsibility. This rapidly growing segment is driven by increasing consumer awareness about responsible pharmaceutical practices and preference for medications tested through transparent clinical trials that minimize risk to human health. As ethical standards assume greater significance among patients and healthcare providers, more drug makers are embracing principles of ethical research, informed consent, environmental stewardship, and fair pricing to gain a competitive edge in this market.

Market Dynamics:

The ethical pharmaceuticals market is primarily driven by growing demand for safe, sustainably-produced, and ethically-tested drugs. Stringent regulatory norms around clinical trials and manufacturing practices are also boosting this segment. Additionally, increasing investments by leading innovator companies in ethical drug development present lucrative opportunities. However, the high costs associated with ethics compliance and sustainability initiatives remain a major challenge for market participants. Moreover, pricing pressures due to growing generics competition can act as a restraint. Adoption of blockchain and artificial intelligence enabled platforms for transparency is another key trend enabling real-time data sharing across value chains.

Key Features of the Study:

This report provides an in-depth analysis of the global ethical pharmaceuticals market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global ethical pharmaceuticals market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Abbott Laboratories, AbbVie Inc, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Amgen Inc, Merck & Co., Inc, GlaxoSmithKline plc, Sanofi, Novartis AG, Otsuka Holdings, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Pfizer Inc, and Takeda Pharmaceutical Company
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global ethical pharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ethical pharmaceuticals market

Detailed Segmentation:

By Therapeutic Class:
- Hormonal Contraceptives
- Respiratory Agents
- Lipid Regulators
- Calcium Antagonists
- ACE Inhibitors
- Narcotic Analgesics
- Others
By End User:
- Hospitals & Clinics
- Pharmaceutical Companies
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Amgen Inc
- AbbVie Inc
- Johnson & Johnson
- Eli Lilly and Company
- Merck & Co., Inc
- GlaxoSmithKline plc
- Sanofi
- Novartis AG
- Abbott Laboratories
- Otsuka Holdings
- Hoffmann-La Roche Ltd
- Teva Pharmaceutical Industries Ltd.
- Pfizer Inc
- Takeda Pharmaceutical Company

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, by Therapeutic Class
- Market Snapshot, By End User
- Market Snapshot, By Region
- Market Scenario - Conservative, Likely, Opportunistic
Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancements
Merger, Acquisition, and Collaboration Scenario
Recent Product Approvals
Company Market Share Analysis
Pricing Analysis
Product Recalls
Pipeline Analysis

4. Global Ethical Pharmaceuticals Market, Therapeutic Class, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Hormonal Contraceptives, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Respiratory Agents, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Lipid Regulators, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Calcium Antagonists, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
ACE Inhibitors, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Narcotic Analgesics, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

5. Global Ethical Pharmaceuticals Market, End User, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Hospitals & Clinics, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Pharmaceutical Companies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

6. Global Ethical Pharmaceuticals Market, By Region, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
- Market Y-o-Y Growth Comparison (%), 2020 - 2031, (US$ Billion)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, Therapeutic Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, Therapeutic Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Therapeutic Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
Australia
South Korea
Asean
Rest Of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, Therapeutic Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, Therapeutic Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest Of The Middle East
Africa
- Introduction
- Market Size and Forecast, Therapeutic Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)
South Africa
North Africa
Central Africa

7. Company Profiles - Global Ethical Pharmaceuticals Market

Amgen Inc*
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
AbbVie Inc
Johnson & Johnson
Eli Lilly and Company
Merck & Co., Inc
GlaxoSmithKline plc
Sanofi
Novartis AG
Abbott Laboratories
Otsuka Holdings
F. Hoffmann-La Roche Ltd
Teva Pharmaceutical Industries Ltd.
Pfizer Inc
Takeda Pharmaceutical Company